BioSpace News Archive

ReForm Biologics, Inc., a company developing a new generation of innovative biologic medicines to improve patient access, safety, and convenience, announced the appointment of four new Directors with significant life science and biotechnology experience: Roopom Banerjee, Kirsten Flowers, Stuart Randle and Edward Sullivan.

AIM ImmunoTech Inc. (NYSE American: AIM) today announced positive progress with the company’s meeting request to the U.S. Food and Drug Administration (FDA) concerning a Phase 2 clinical study of Ampligen

Vildagliptin is an antihyperglycemic medication that inhibits the dipeptidyl peptidase-4 enzyme selectively.

TMR Research is a leader in developing well-researched reports. The expertise of the researchers at TMR Research makes the report stand out from others.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per the insights by Fact.MR, the global rare neurological disease treatment market is set to expand by 2.3X, exhibiting a CAGR of over 8.5% over the forecast period 2018-2028.

TMR Research has rich experience in developing state-of-the-art reports for a wide array of markets and sectors.

CorWave, a French medtech developing a next-generation heart pump, is recruiting top talent from throughout the world to strengthen its team.

Seneca Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of targeted oncolytic immunotherapeutics for cancer based on Seneca Valley Virus, announced the launch of a novel Cancer Gene Delivery Platform based on SVV-001 technology.

Johnson & Johnson announced new data reinforcing the strong and long-lasting protection of its COVID-19 vaccine.

BioCryst Pharmaceuticals, Inc. announced that the company will present at the 2021 Cantor Virtual Healthcare Conference on Tuesday, September 28, 2021 at 2:00 p.m. ET.